A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity-Reference-Cited by-同舟云学术

A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity

Published:2005-05 Issue:20 Volume:280 Page:19665-19672
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lu Dan,Zhang Haifan,Koo Henry,Tonra James,Balderes Paul,Prewett Marie,Corcoran Eric,Mangalampalli Venkata,Bassi Rajiv,Anselma Deborah,Patel Dipa,Kang Xiaoqiang,Ludwig Dale L.,Hicklin Daniel J.,Bohlen Peter,Witte Larry,Zhu Zhenping

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference51 articles.

1. Clinical trials of antibody therapy

2. Anticancer Antibodies

3. Herceptin^® Alone or in Combination with Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Pivotal Trials

4. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update;Molecular Biotechnology;2024-06-01

2. Monoclonal Antibody Development for Cancer Treatment Using the Phage Display Library Platform;Biologics;2024-02-23

3. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications;Cells;2023-12-25

4. Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors;JAMA Network Open;2023-07-28

5. Targeted therapy;Medicines for Cancer;2023